Severe pulmonary hypertension in Anti-Jo-1 syndrome

Arthritis Care and Research

Volumn 62, Issue 3, 2010, Pages 425-429

  Chatterjee, Soumya ^a   Farver, Carol ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FUROSEMIDE; PREDNISONE; SILDENAFIL; UNIPROST; WARFARIN;

ADULT; ANTISYNTHETASE SYNDROME; ARTICLE; AUTOPSY; BRONCHIECTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; ENZYME IMMUNOASSAY; FEMALE; FIBROSING ALVEOLITIS; HEART CATHETERIZATION; HUMAN; INTERSTITIAL LUNG DISEASE; JO 1 ANTIBODY SYNDROME; LUNG FUNCTION TEST; PHYSICAL EXAMINATION; PLEURA EFFUSION; PULMONARY HYPERTENSION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; FATAL OUTCOME; FEMALE; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY, LEFT VENTRICULAR; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; SYNDROME;

EID: 77649225536     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20109     Document Type: Article

References (17)

1. Imbert-Masseau A, Hamidou M, Agard C, Grolleau JY, Cherin P. Antisynthetase syndrome. Joint Bone Spine 2003;70:161-8.
2. Proudman SM, Stevens WM, Sahhar J, Celermajer D. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J 2007;37:485-94.
3. Bull TM, Fagan KA, Badesch DB. Pulmonary vascular manifestations of mixed connective tissue disease. Rheum Dis Clin North Am 2005;31:451-64.
4. Heresi GA, Minai OA. Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy. Respir Med 2007;101:2099-107.
5. Asherson RA, Cervera R. Pulmonary hypertension, antiphospholipid antibodies, and syndromes. Clin Rev Allergy Immunol 2007;32:153-8.
6. Vassiliou VA, Moyssakis I, Boki KA, Moutsopoulos HM. Is the heart affected in primary Sjögren's syndrome? An echocardiographic study. Clin Exp Rheumatol 2008;26:109-12.
7. Dawson JK, Goodson NG, Graham DR, Lynch MP. Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients. Rheumatology (Oxford) 2000;39:1320-5.
8. Polomis D, Runo JR, Meyer KC. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med 2008;14:462-9.
9. Gagermeier J, Dauber J, Yousem S, Gibson K, Kaminski N. Abnormal vascular phenotypes in patients with idiopathic pulmonary fibrosis and secondary pulmonary hypertension [abstract]. Chest 2005;128 Suppl:601S.
10. Bunch TW, Tancredi RG, Lie JT. Pulmonary hypertension in polymyositis. Chest 1981;79:105-7.
11. Handa T, Nagai S, Kawabata D, Nagao T, Takemura M, Kitaichi M, et al. Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. Intern Med 2005;44:319-25.
12. Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? J Anat 2002;201:335-48.
13. Tuder RM, Cool CD, Yeager M, Taraseviciene-Stewart L, Bull TM, Voelkel NF. The pathobiology of pulmonary hypertension: endothelium. Clin Chest Med 2001;22:405-18.
14. Grassegger A, Pohla-Gubo G, Frauscher M, Hintner H. Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis. Wien Med Wochenschr 2008;158:19-28.
15. Selimovic N, Bergh CH, Andersson B, Sakiniene E, Carlsten H, Rundqvist B. Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension. Eur Respir J 2009;34:662-8.
16. Benisty JI, McLaughlin VV, Landzberg MJ, Rich JD, Newburger JW, Rich S, et al. Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension. Chest 2004;126:1255-61.
17. Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, et al. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2008;178:81-8.